Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Perioperative Hemodynamic Goal-directed Therapy in Major Abdominal Surgery (iPEGASUS-trial) - A Multi-center, Prospective, Randomized Trial

NCT03021525 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

NCT NCT03021525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03021525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Perioperative Hemodynamic Goal-directed Therapy in Major Abdominal Surgery (iPEGASUS-trial) - A Multi-center, Prospective, Randomized Trial
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Not applicable
Overall status
Completed
Start date
August 29, 2017
Completion date
August 26, 2023
Enrollment
380 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac output, high, hemodynamic instability, peroperative complication